Skip to main content

Featured

BoC Decision Day: What a Hold at 2.25% Means for Your Mortgage

  Published September 2, 2026 Tomorrow's date has been sitting at the bottom of every Canadian Money Brief for weeks, and it's finally here. The Bank of Canada announces its overnight rate decision on Wednesday, September 2 at 9:45 a.m. ET, with Governor Tiff Macklem holding a press conference at 10:30. Every economist polled by Reuters — all 35 of them — expects the same outcome: a hold at 2.25%, the eighth straight meeting without a move. That's the headline. The more useful question for your wallet is what a "boring" hold actually does — and doesn't do — to your mortgage, and why two of the Big Six banks think the boring streak is about to end. Why a hold is the almost-certain call The Bank has a genuinely awkward setup heading into this meeting. On one side, the economy just posted its best quarter in years: GDP grew at a 3.3% annualized pace in the second quarter, well ahead of the Bank's own 2.5% forecast, and July's jobs report added a blowout ...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment